Ellex

No results found

Check the spelling or try searching for a more general term.

Quick Links

Select your location

Share price summary

Share price

ASX (ELX)

0.71AUD

±0

Last updated 05:54pm 3/07/2020 GMT+10:30

Latest

Offered $3.3M AusIndustry Research & Development Grant

9 January, 2004

asx

Appendix 3B - Employee share option plan

22 January, 2004

asx

New Distribution Initiative

23 January, 2004

asx

Half Yearly Report & Half Year Accounts

18 February, 2004

asx

Half Year Results Presentation

18 February, 2004

asx

December 2003 Half Year Release

18 February, 2004

asx

Japan Regulatory Approval Secured - First Sales

30 March, 2004

asx

Change of Director's Interest Notice

22 April, 2004

asx

ELXOB Options Expiring 31 May 2004

30 April, 2004

asx

$0.50 Options Expiring 25 July 2004 (ELXOA)

28 June, 2004

asx

Date for Financial Year 2004 Full Year Results

16 August, 2004

asx

Preliminary Final Report

27 August, 2004

asx

Lays platform for growth

27 August, 2004

asx

Full Year Accounts

29 September, 2004

asx

Notice of Annual General Meeting

8 October, 2004

asx

Annual Report

26 October, 2004

asx

Launces new Photocoagulator

5 November, 2004

asx

Chairman's AGM Address to Shareholders

25 November, 2004

asx

Press Release - 2004 AGM

25 November, 2004

asx

Managing Director's Presentation - 2004 AGM

25 November, 2004

asx

Results of 2004 AGM

25 November, 2004

asx

Half Yearly Report & Half Year Accounts

18 February, 2005

asx

December 2004 Half Year Release

18 February, 2005

asx

Restructure of Senior Management

28 February, 2005

asx

Resignation of Director

19 April, 2005

asx

Change of Director's Interest Notice

14 June, 2005

asx

Solitaire Release and R&D Reorganisation

20 June, 2005

asx

Change of Director's Interest Notice

1 July, 2005

asx

Final Director's Interest Notice

8 July, 2005

asx

Board Changes

25 July, 2005

asx

Initial Director's Interest Notice

27 July, 2005

asx

Final Director's Interest Notice

27 July, 2005

asx

Date for Release of Appendix 4E and AGM

11 August, 2005

asx

Preliminary Final Report & Full Year Accounts

8 September, 2005

asx

FY2005 Results Announcement

8 September, 2005

asx

Change of Director's Interest Notice

22 September, 2005

asx

Issue of Options to Senior Executives

7 October, 2005

asx

Change of Director's Interest Notice

13 October, 2005

asx

Change of Director's Interest Notice

21 October, 2005

asx

Notice of Annual General Meeting

26 October, 2005

asx

Annual Report

26 October, 2005

asx

Investor Presentation

2 November, 2005

asx

IFRS Update

2 November, 2005

asx

Ellex to seek EOI for Adelaide Property

7 November, 2005

asx

Extends Research & Development Grant

16 November, 2005

asx

Chairman's Address to AGM

28 November, 2005

asx

CEO Presentation to AGM

28 November, 2005

asx

Results of Meeting

29 November, 2005

asx

Change of Director's Interest Notice

5 December, 2005

asx

Becoming a substantial holder

5 December, 2005

asx

Appendix 3B

7 December, 2005

asx

Change of Director's Interest Notice

7 December, 2005

asx

Change of Director's Interest Notice

16 December, 2005

asx

Sale of Building

19 January, 2006

asx

Change in substantial holding from CBA

28 February, 2006

asx

Half Yearly Report & Half Year Accounts

1 March, 2006

asx

Press Release: Half Year Results

1 March, 2006

asx

Launches New Brand at ASCRS Trade Show in San Francisco

17 March, 2006

asx

New Product Launch - Integre Duo

20 March, 2006

asx

Ellex to Present at Citigroup Conference

31 March, 2006

asx

Presentation to Citigroup Microcap Conference

3 April, 2006

asx

Receives FDA approval for new photocoagulator

11 April, 2006

asx

Appointment of Chief Operating Officer

27 April, 2006

asx

Appoints first direct sales person in US

6 June, 2006

asx

Appointment of VP Operations

25 July, 2006

asx

To acquire Coherent Lasers (Australia) Pty ltd

21 August, 2006

asx

Preliminary Final Report & Full Year Accounts

23 August, 2006

asx

FY2006 Results August 2006

23 August, 2006

asx

Press Release: Full Year 2006

23 August, 2006

asx

2006 Annual Report

28 September, 2006

asx

Direct Sales Channel in Australia

3 October, 2006

asx

Response to ASX Query re Share Price

4 October, 2006

asx

Appendix 3B

31 October, 2006

asx

Chairman's Address to AGM

2 November, 2006

asx

CEO Presentation to AGM

2 November, 2006

asx

Results of AGM

2 November, 2006

asx

Appendix 3B Exercise of Employee Share Options

7 November, 2006

asx

Appendix 3B

28 November, 2006

asx

Acquires Innovative Imaging

4 December, 2006

asx

Appendix 3B

13 December, 2006

asx

Appendix 3B

21 December, 2006

asx

Awarded AusIndustry Grant for AMD Laser Researc h

14 February, 2007

asx

Appendix 3B

26 February, 2007

asx

Half Yearly Report & Accounts

27 February, 2007

asx

Press Release - Half Year Results

27 February, 2007

asx

Investor Presentation HY07

5 March, 2007

asx

Notice of Annual General Meeting

9 March, 2007

asx

Enters Chinese Opthalmic Market

5 April, 2007

asx

Ellex gains US FDA approval for 30XL Laser Slit Lamp

23 April, 2007

asx

Trading Halt

22 June, 2007

asx

Raises $5.5 million Through Placement

26 June, 2007

asx

Appendix 3B

29 June, 2007

asx

Section 708A Notice

29 June, 2007

asx

Appendix 3B

19 July, 2007

asx

Appoints VP of US Sales

2 August, 2007

asx

Press Release - Ellex FY2007 Year End Results

23 August, 2007

asx

Preliminary Final Report

23 August, 2007

asx

Investor Presentation - FY2007 Year End Results

23 August, 2007

asx

Change of Director`s Interest Notice

4 October, 2007

asx

Appointment of Directors

15 October, 2007

asx

Notice of Annual General Meeting

26 October, 2007

asx

Annual Report to shareholders

26 October, 2007

asx

Letter to Shareholders

26 October, 2007

asx

Initial Director`s Interest Notice

31 October, 2007

asx

Initial Director`s Interest Notice

31 October, 2007

asx

New Retina Regeneration Therapy to be Presented at the AAO

1 November, 2007

asx

Ellex 2RT Demonstrates Clinical Efficacy in Retinal Trial

12 November, 2007

asx

Appoints Warwick Kitt to Ellex Australia Board

23 November, 2007

asx

Chairman and CEO Presentation to AGM

27 November, 2007

asx

Results of AGM

28 November, 2007

asx

Update of FY08 First Half and Outlook for Year

31 January, 2008

asx

Half Yearly Report and Accounts

26 February, 2008

asx

Ellex FY2008 Half Year Results

26 February, 2008

asx

Ellex Appoints Tony Mitchell as CFO

3 March, 2008

asx

Investor Presentation - FY2008 Half Year

3 March, 2008

asx

Change of Director`s Interest Notice

11 March, 2008

asx

Appendix 3B

31 March, 2008

asx

Update on Outlook for FY08 Result

2 May, 2008

asx

Outcome of Tax Audit

14 May, 2008

asx

Trading Halt

23 June, 2008

asx

Company`s Request for Trading Halt

23 June, 2008

asx

Position of CEO and Outlook for FY08

25 June, 2008

asx

Investor Presentation

1 July, 2008

asx

Appendix 3B

24 July, 2008

asx

Final Director`s Interest Notice

25 July, 2008

asx

FY08 Full Year Results Presentation

27 August, 2008

asx

FY08 Full Year Results Press Release

27 August, 2008

asx

Preliminary Final Report

27 August, 2008

asx

Ellex commences direct sales in Germany

10 September, 2008

asx

Notice of members resolution at general meeting

24 September, 2008

asx

Annual Report to shareholders

30 September, 2008

asx

Date of 2008 Annual General Meeting

15 October, 2008

asx

Director and Advisor Appointments

17 October, 2008

asx

Appendix 3B

20 October, 2008

asx

Appointment of New CEO

22 October, 2008

asx

Appendix 3X Initial Directors Interest Notice

23 October, 2008

asx

Appendix 3X Initial Directors Interest Notice

23 October, 2008

asx

Appendix 3Z Final Directors Interest Notice

23 October, 2008

asx

Notice of Annual General Meeting

27 October, 2008

asx

Proxy Form

27 October, 2008

asx

Appointment of New CFO, Company Secretary

28 October, 2008

asx

Ellex to Review Foreign Exchange Hedging Contracts

31 October, 2008

asx

Ellex to Preview New Multi-Colour Photocoagulation Laser

4 November, 2008

asx

Ellex Announces 6-Mth Results on Retina Regeneration Therapy

10 November, 2008

asx

Becoming a substantial holder

19 November, 2008

asx

Becoming a substantial holder

19 November, 2008

asx

2008 AGM Presentation

28 November, 2008

asx

Trading Halt

1 December, 2008

asx

Results of Meeting

1 December, 2008

asx

Non-Renounceable Rights Offer

1 December, 2008

asx

Appendix 3B

2 December, 2008

asx

Cleansing Statement

2 December, 2008

asx

Non-Renounceable Rights Issue Letter of Offer

2 December, 2008

asx

Despatch of Letter to Shareholders

2 December, 2008

asx

Change in substantial holding from CBA

10 December, 2008

asx

Second Cleansing Notice

10 December, 2008

asx

Despatch of Letter to Shareholders

12 December, 2008

asx

Second Cleansing Notice

12 December, 2008

asx

Ceasing to be a substantial holder from CBA

16 December, 2008

asx

Ellex Market Update

19 December, 2008

asx

Update on Underwriting of Non-Renounceable Issue

30 December, 2008

asx

Notice under Appendix 7A of the ASX Listing Rules

6 January, 2009

asx

Change of Director`s Interest Notice

20 January, 2009

asx

Appendix 3B

20 January, 2009

asx

Change of Director`s Interest Notice

20 January, 2009

asx

Change of Director`s Interest Notice

20 January, 2009

asx

Response to ASX Query re Appendix 3Y

21 January, 2009

asx

Change in substantial holding

21 January, 2009

asx

Change in substantial holding

21 January, 2009

asx

Appendix 3B

3 February, 2009

asx

Ellex Reports Record First Half Revenue

26 February, 2009

asx

Half Yearly Report and Accounts

26 February, 2009

asx

Appendix 3Y

2 March, 2009

asx

Appendix 3Y

3 March, 2009

asx

Response to ASX Query Re Appendix 4D

6 March, 2009

asx

Ellex Appoints General Manager, Ellex Australia

1 April, 2009

asx

Banking Facility Extended

13 May, 2009

asx

Ellex Reaches Milestone in SLT Laser Sales

10 June, 2009

asx

Appendix 4E

27 August, 2009

asx

FY09 Year End Results

27 August, 2009

asx

Final Appendix 4E and Full Year Annual Report

22 September, 2009

asx

Ellex to Deliver New General Ultrasound at AAO

23 October, 2009

asx

Annual Report to shareholders

23 October, 2009

asx

Notice of Annual General Meeting

26 October, 2009

asx

Proxy Form

26 October, 2009

asx

Westpac Banking Facility Extended to 30 September 2011

10 November, 2009

asx

Ellex 2RT Research Program Awarded Government Grant

13 November, 2009

asx

2009 AGM Presentation

26 November, 2009

asx

Results of Meeting

8 December, 2009

asx

Trading Update

17 December, 2009

asx

Ellex Delivers Industry`s First Integrated Yellow Laser

22 January, 2010

asx

Market Update

9 February, 2010

asx

Half Yearly Report and Accounts

25 February, 2010

asx

Ellex FY2010 Half Year Results and Highlights

25 February, 2010

asx

Full Copy - Half Yearly Report and Accounts

2 March, 2010

asx

Change of Director`s Interest Notice

10 March, 2010

asx

Ellex Secures Sublicense Agreement for Ellex 2RT

12 April, 2010

asx

Ellex to Present New Clinical Results for Ellex 2RT at ARVO

3 May, 2010

asx

Ellex 2RT Studies Demonstrate Clinical Efficacy

7 May, 2010

asx

Appendix 3B

10 August, 2010

asx

Profit Upgrade Guidance - Ellex 2010 Financial Year

18 August, 2010

asx

Appendix 4E and FY2010 Annual Report

26 August, 2010

asx

Ellex Full Year Results 2010

26 August, 2010

asx

Ellex Secures Major Distribution Deal with CenterVue

12 October, 2010

asx

Appendix 3B

14 October, 2010

asx

Annual Report to shareholders

25 October, 2010

asx

Notice of Annual General Meeting

25 October, 2010

asx

Notice of Annual General Meeting/Proxy Form

25 October, 2010

asx

Ellex Secures Additional Distribution Deal with CenterVue

3 November, 2010

asx

Ellex to Preview New Laser for Treatment of AMD

17 November, 2010

asx

2010 AGM Presentation

25 November, 2010

asx

Results of 2010 Annual General Meeting

25 November, 2010

asx

Constitution

2 December, 2010

asx

Trading Policy

15 December, 2010

asx

Trading Update - Half-Year Result 2011 Financial Year

7 January, 2011

asx

Trading Policy

31 January, 2011

asx

Ellex FY2011 Half-Year Results

24 February, 2011

asx

Half Yearly Report and Accounts

24 February, 2011

asx

Ellex Enters Ophthalmic Lens Market

10 March, 2011

asx

Ellex to Deliver New Diagnostic Ultrasound Mode at ASCRS

23 March, 2011

asx

Company Update - New CEO and Executive Appointment

31 March, 2011

asx

Positive Ellex 2RT Data Demonstrates Efficacy for Early AMD

3 May, 2011

asx

Ellex to Deliver Improved Manufacturing Efficiencies

21 June, 2011

asx

Trading Update - Full-Year Result 2011 Financial Year

21 July, 2011

asx

Ellex Announces Full-Year Results for 2011 Financial Year

30 August, 2011

asx

Ellex Appendix 4E Preliminary Final Report FY2011

30 August, 2011

asx

Director Appointment/Resignation

23 September, 2011

asx

Final Director`s Interest Notice

29 September, 2011

asx

Ellex Annual Report FY2011

29 September, 2011

asx

Ellex Launches Innovative Medical Laser Technology

20 October, 2011

asx

Notice of Annual General Meeting/Proxy Form

16 November, 2011

asx

Notice of Annual General Meeting/Proxy Form

16 November, 2011

asx

2011 AGM Presentation

24 November, 2011

asx

Results of Meeting

24 November, 2011

asx

Trading Update

2 February, 2012

asx

Half Yearly Report and Accounts

23 February, 2012

asx

Ellex Announces Half-Year Results for 2012 Financial Year

23 February, 2012

asx

Ellex acquires minority interest in Ellex Australia Pty Ltd

28 February, 2012

asx

Ellex Investor Presentation March 2012

19 March, 2012

asx

Ellex Secures CE Mark for Retinal Rejuvenation Therapy

18 July, 2012

asx

Trading Update - Large Turnaround to Profit in FY12

23 July, 2012

asx

Appendix 4E and Full Year Statutory Accounts

30 August, 2012

asx

Ellex Announces Full-Year Result for FY 2012

30 August, 2012

asx

Ellex Investor Presentation September 2012

3 September, 2012

asx

Annual Report to shareholders

29 October, 2012

asx

Notice of Annual General Meeting/Proxy Form

29 October, 2012

asx

Ellex Secures Contract Manufacturing Agreement

1 November, 2012

asx

Ellex Launches New Ophthalmic Products at American Academy

7 November, 2012

asx

Ellex Announces Commencement of Patient Recruitment for Clin

23 November, 2012

asx

Ellex 2012 AGM Presentation

29 November, 2012

asx

Results of Meeting

29 November, 2012

asx

Results of 2012 AGM Incorporating Proxy Results

29 November, 2012

asx

Company Secretary Appointment/Resignation

7 January, 2013

asx

Trading Update - Half-Year Result 2013 Financial Year

30 January, 2013

asx

Half Yearly Report and Accounts

27 February, 2013

asx

Investor Presentation for H1FY13

8 March, 2013

asx

Director Appointment/Resignation

4 April, 2013

asx

Final Director's Interest Notice

11 April, 2013

asx

Director Appointments

17 May, 2013

asx

Initial Director's Interest Notice

21 May, 2013

asx

Initial Director's Interest Notice

21 May, 2013

asx

Ellex Launches Glaucoma Laser Platform in the USA

11 July, 2013

asx

Ellex Secures US FDA Approval for 2RT

18 July, 2013

asx

Ellex Trading Update - Full-Year Results for FY2013

14 August, 2013

asx

Appendix 4E & Full Year Statutory Accounts

29 August, 2013

asx

Ellex announces Full-Year Results for FY2013

29 August, 2013

asx

Ellex Achieves Key Milestones in 2RT Clinical Trial Program

4 September, 2013

asx

Ellex Investor Presentation 2013

12 September, 2013

asx

Trading Halt

17 September, 2013

asx

Ellex Completes Successful Placement to Raise $3.3 Million

19 September, 2013

asx

Ellex Secures US Government Qualification for SLT Lasers

26 September, 2013

asx

Cleansing Notice - Placement

3 October, 2013

asx

Appendix 3B

3 October, 2013

asx

Becoming a substantial holder

3 October, 2013

asx

Becoming a substantial holder from AEF

3 October, 2013

asx

Release of Positive Pilot Study Results for 2RT Treatment

14 October, 2013

asx

Annual Report to shareholders

24 October, 2013

asx

Notice of Annual General Meeting/Proxy Form

24 October, 2013

asx

Change in substantial holding from AEF

1 November, 2013

asx

ELX USA SLT Glaucoma Laser Update

12 November, 2013

asx

Ellex AGM Presentation

28 November, 2013

asx

Results of Meeting

28 November, 2013

asx

Trading Halt

18 December, 2013

asx

Acquistion and Capital Raise

20 December, 2013

asx

Appendix 3B

3 January, 2014

asx

Ellex Completes Acquisition of Canaloplasty Business

6 January, 2014

asx

Change of substantial holder from AEF

7 January, 2014

asx

Trading Update for half-year ended 31 December 2013

30 January, 2014

asx

Ellex - CE Mark for 2RT Treatment of Early Stage AMD

24 February, 2014

asx

Half Yearly Report and Accounts

27 February, 2014

asx

Investor Presentation for H1FY14

19 March, 2014

asx

ELX announces further results for 2RT treatment of early AMD

15 May, 2014

asx

Commercial Sales of 2RT Laser

8 July, 2014

asx

Trading Update FY14 Results

5 August, 2014

asx

Appendix 4E & Full-Year Statutory Accounts

29 August, 2014

asx

Ellex announces Full-Year Results for FY2014

29 August, 2014

asx

Ellex - 2RT Laser Clinical Update at ESCRS

12 September, 2014

asx

Ellex US Investor Presentation 2014

18 September, 2014

asx

Ellex Investor Presentation 2014

23 September, 2014

asx

Annual Report to Shareholders

22 October, 2014

asx

Notice of Annual General Meeting/Proxy Form

22 October, 2014

asx

Canaloplasty Glaucoma Surgery Recognised as Gold Standard

29 October, 2014

asx

Change of Director's Interest Notice

10 November, 2014

asx

Change of Director's Interest Notice

10 November, 2014

asx

Change of Director's Interest Notice

12 November, 2014

asx

Further positive clinical data on 2RT

18 November, 2014

asx

CEO's AGM Presentation

26 November, 2014

asx

Shareholder Update at AGM

26 November, 2014

asx

Results of Meeting

26 November, 2014

asx

Trading Update for the half-year ended 31 December 2014

29 January, 2015

asx

2RT Makes Headline in Peer-Review Publication

5 February, 2015

asx

Half Yearly Report and Accounts

27 February, 2015

asx

Half Yearly Results FY15

27 February, 2015

asx

Investor Presentation H1FY15

27 February, 2015

asx

Ellex attending major tradeshow in China

30 March, 2015

asx

Ellex lifts Global Market Share

6 May, 2015

asx

More Scientific Research Validates Clinical Effect of 2RT

19 May, 2015

asx

2RT Grant Awarded, Commercial Update

14 July, 2015

asx

Trading Update for the Full Year Ended 30 June 2015

30 July, 2015

asx

ELX Preliminary Financial Report Appendix 4E FY15

27 August, 2015

asx

Ellex Report Full Year 2015 Preliminary Report Appendix 4E

27 August, 2015

asx

ELX Investor Presentation FY15 Results

27 August, 2015

asx

Ellex releases first case study results for 2RT at tradeshow

14 September, 2015

asx

Annual Report to shareholders

29 September, 2015

asx

Appendix 4G

29 September, 2015

asx

Corporate Governance Statement

30 September, 2015

asx

Ellex Market Expansion into MIGS

1 October, 2015

asx

ELX Sales Strategy Yields Positive Results in First Quarter

8 October, 2015

asx

Notice of Annual General Meeting/Proxy Form

23 October, 2015

asx

ELX iTrack Achieves Further Market Traction

4 November, 2015

asx

2015 AGM Script

25 November, 2015

asx

2015 CEO's AGM Presentation

25 November, 2015

asx

Results of Meeting

25 November, 2015

asx

Ellex provides a Summary of ABiC iTrack Opportunity

4 December, 2015

asx

Change in Substantial Holding from AEF

11 January, 2016

asx

ELX expands production facilities to meet demand

22 January, 2016

asx

Trading Update for Half-Year Ended 31 December 2015

29 January, 2016

asx

Half Yearly Report and Accounts

26 February, 2016

asx

ELX 1H FY16 ASX Release and Investor Presentation

26 February, 2016

asx

Change in Substantial Holding from AEF

14 March, 2016

asx

Change in substantial holding from AEF - correction

16 March, 2016

asx

Trading Halt

6 April, 2016

asx

Ellex raises $5 million

7 April, 2016

asx

Cleansing Notice

13 April, 2016

asx

Appendix 3B

13 April, 2016

asx

Change in Substantial Holding from AEF

15 April, 2016

asx

Ellex Announces Positive iTrack 12-Month Data

6 May, 2016

asx

Ellex Announces Interim Review for 2RT Clinical Trial

30 May, 2016

asx

Change of Director's Interest Notice

6 June, 2016

asx

China FDA Approval for Ophthalmic Treatment Lasers

15 June, 2016

asx

Change in substantial holding from AEF

19 July, 2016

asx

Trading Update for Full Year Ended 30 June 2016

28 July, 2016

asx

Ellex awarded $2.5m Federal Government Grant

26 August, 2016

asx

Ellex - Appendix 4E & Full Year Statutory Accounts 2016

29 August, 2016

asx

Ellex announces FY Results for 2016

29 August, 2016

asx

Ellex Investor Presentation Y16 Results

29 August, 2016

asx

Ellex Announces Launch of New Ophthalmic Ultrasound Device

6 September, 2016

asx

Corporate Governance Statement

3 October, 2016

asx

Appendix 4G

3 October, 2016

asx

Change of Director's Interest Notice

5 October, 2016

asx

Change in substantial holding from AEF

7 October, 2016

asx

Change of Director's Interest Notice

17 October, 2016

asx

Annual Report to shareholders

21 October, 2016

asx

Notice of Annual General Meeting

21 October, 2016

asx

ELX announces iTrack USA Reimbursement Increase

10 November, 2016

asx

2016 AGM Script

23 November, 2016

asx

2016 CEO's AGM Presentation

23 November, 2016

asx

Results of Meeting

23 November, 2016

asx

Trading Halt

30 November, 2016

asx

Ellex raises $10.3 million

1 December, 2016

asx

Appendix 3B

9 December, 2016

asx

Cleansing Statement

9 December, 2016

asx

Amended Appendix 3B

9 December, 2016

asx

Ellex iTrack commencement of clincal training in China

15 December, 2016

asx

Trading Update for Half-Year Ended 31 December 2016

2 February, 2017

asx

Clarification to Trading Update for Half-Year Ended 311216

2 February, 2017

asx

Half Yearly Report & Accounts

27 February, 2017

asx

ELX 1H FY17 ASX Release & Investor Presentation

27 February, 2017

asx

ELX presentation to Ophthalmology Futures Asian Forum 2017

1 March, 2017

asx

S&P DJ Indices Announces March Quarterly Rebalance

10 March, 2017

asx

Ellex iTrack ASCRS

5 May, 2017

asx

Change in substantial holding from AEF

11 May, 2017

asx

ELX Site Tour of Institutional Shareholders & Analysts

19 May, 2017

asx

Ellex acquires future royalty for iTrack

30 May, 2017

asx

Ellex iTrack approval in China extended

6 June, 2017

asx

Ellex iTrack Sales and Marketing Update

22 June, 2017

asx

Ellex Sales Trading Update

6 July, 2017

asx

Ellex Reflex Technology published in peer-review journal

21 July, 2017

asx

Ellex Company Update

25 July, 2017

asx

Ellex FY17 Trading Update Earnings

28 July, 2017

asx

ELX Milestone achieved for Ellex iTrack in China

31 July, 2017

asx

Full Year FY17 Audited Results

25 August, 2017

asx

Ellex Strengthens IP Portfolio for 2RT

29 August, 2017

asx

Ellex iTrack Production Capacity Expansion

1 September, 2017

asx

Change in substantial holding from AEF

28 September, 2017

asx

Full Year Audited Statutory Accounts

29 September, 2017

asx

Appendix 4G

29 September, 2017

asx

Corporate Governance Statement

29 September, 2017

asx

Ellex iTrack Sales for Quarter Ended 30 September 2017

3 October, 2017

asx

Ellex Corporate Presentation

20 October, 2017

asx

Notice of Annual General Meeting

27 October, 2017

asx

Annual Report to Shareholders

27 October, 2017

asx

Trading Halt

1 November, 2017

asx

Equity Captial for Ellex iTrack Expansion

3 November, 2017

asx

Notice of Extraordinary General Meeting

7 November, 2017

asx

Appendix 3B

7 November, 2017

asx

Cleansing Statement 7th November allocation

8 November, 2017

asx

Appendix 3B

9 November, 2017

asx

Cleansing Statement 8th November 2017

9 November, 2017

asx

Completion of Tranche 1 Placement

9 November, 2017

asx

Cleansing Notice - Share Purchase Plan

14 November, 2017

asx

Availability of Ellex SPP offer documents

14 November, 2017

asx

Share Purchase Plan and Application Form

14 November, 2017

asx

Update Following Major USA Tradeshow

17 November, 2017

asx

Extension of Closing Date of Share Purchase Plan

23 November, 2017

asx

2017 CEO's AGM Presentation

28 November, 2017

asx

2017 AGM Script

28 November, 2017

asx

2017 AGM script

28 November, 2017

asx

Results of Meeting

28 November, 2017

asx

Results of Meeting

8 December, 2017

asx

Appendix 3B

13 December, 2017

asx

Cleansing Statement 14 December 2017

14 December, 2017

asx

Becoming a substantial holder

18 December, 2017

asx

Appendix 3B - Share Purchase Plan

22 December, 2017

asx

Share Purchase Plan Closure and Tranche 2 Placement

22 December, 2017

asx

Revised Appendix 3B

4 January, 2018

asx

Becoming a substantial holder

15 January, 2018

asx

Ceasing to be a substantial holder

17 January, 2018

asx

Trading Update for Half Year Ended 31 December 2017

5 February, 2018

asx

Half Year Accounts for 31 December 2017

27 February, 2018

asx

Ellex at American Glaucoma Society Meeting, New York City

7 March, 2018

asx

S&P DJ Indices Announces March Quarterly Rebalance

9 March, 2018

asx

Additional Financial Information for Half Year

9 March, 2018

asx

Ellex Presentation at Oppenheimer Conference

19 March, 2018

asx

2RT at European Laser Innovation Forum 2018

23 March, 2018

asx

Glaucoma Technologies at US Tradeshow ASCRS 2018

10 April, 2018

asx

Glaucoma Business FY18Q3 Sales Update

16 April, 2018

asx

Change of Director's Interest Notice

14 May, 2018

asx

Director Appointment/Resignation

15 May, 2018

asx

Final Director's Interest Notice

15 May, 2018

asx

Change in substantial holding

22 May, 2018

asx

Change of Director's Interest Notice

1 June, 2018

asx

Appointment of Directors

2 July, 2018

asx

Initial Director's Interest Notice

2 July, 2018

asx

Appointment of President Ellex iTrack

11 July, 2018

asx

Trading Update for Year Ended 30th June 2018

27 July, 2018

asx

Ellex on Recent MIGS Device Withdrawal

30 August, 2018

asx

Full Year Statutory Accounts

30 August, 2018

asx

ELX FY18 ASX Release & Investor Presentation

30 August, 2018

asx

Corporate Governance Statement & 4G

30 August, 2018

asx

ELX LEAD Clinical trial results

20 September, 2018

asx

ELX LEAD trial investor call

20 September, 2018

asx

ELX LEAD trial investor presentation

21 September, 2018

asx

ELX US Institutional Roadshow Oct 2018

8 October, 2018

asx

Ellex appoints Dr David Lubeck as Chief Medical Officer

18 October, 2018

asx

Ellex 2RT Sales & Marketing Initiatives at AAO

26 October, 2018

asx

Annual Report to shareholders/Letter to Shareholders

26 October, 2018

asx

Notice of Annual General Meeting/Proxy Form

26 October, 2018

asx

Change in substantial holding

5 November, 2018

asx

2018 CEO AGM Presentation

28 November, 2018

asx

2018 AGM Chair Script

28 November, 2018

asx

Sales Update at AGM

28 November, 2018

asx

Results of Meeting

28 November, 2018

asx

ELX commence trading on USA OTCQX

21 December, 2018

asx

Ellex H1 FY19 Investor Conference Call Details

8 February, 2019

asx

Half Yearly Report and Accounts

22 February, 2019

asx

Investor Presentation FY2019 H1

22 February, 2019

asx

LiGHT Trial Shows SLT More Effective

12 March, 2019

asx

Ellex iTrack featured in the 8th WGC in Melbourne

28 March, 2019

asx

Trading Halt

5 April, 2019

asx

Pause in Trading

5 April, 2019

asx

Trading Halt

5 April, 2019

asx

Ellex Appoints Gerard Wallace as CEO

8 April, 2019

asx

Innovative New Ultrasound Launch at ASCRS

6 May, 2019

asx

Change in substantial holding from AEF

9 May, 2019

asx

Investor Presentation May 2019

27 May, 2019

asx

Lead Shows Positive 2RT Benefits in iAMD Patients at 4 Years

8 July, 2019

asx

Extension to suspension from official quotation

12 December, 2019

asx

$100M Lasers & Ultrasound business sale to Lumibird Group

24 December, 2019

asx

Reinstatement to Official Quotation

24 December, 2019

asx

Change in substantial holding

31 December, 2019

asx

Change in substantial holding

14 January, 2020

asx

Change in substantial holding

21 January, 2020

asx

Resignation of Interim CEO

18 February, 2020

asx

Half Yearly Report and Accounts

20 February, 2020

asx

Investor Presentation FY2020 H1

20 February, 2020

asx

Forfeit of options

28 February, 2020

asx

Notice of Extraordinary General Meeting/Proxy Form

24 March, 2020

asx

Ellex Shareholders to vote on Lumibird transaction

24 March, 2020

asx

Change in substantial holding

14 April, 2020

asx

Update to EGM location and structure

14 April, 2020

asx

Chairman's Address to Shareholders

24 April, 2020

asx

Results of Meeting

24 April, 2020

asx

Update on sale of L&U Business to Lumibird

1 May, 2020

asx

AXX: Lumibird-Ellex deal not opposed

11 June, 2020

asx

ACCC clears Ellex Lumibird transaction

11 June, 2020

asx

Change in substantial holding from AEF

15 June, 2020

asx

Ceasing to be a substantial holder

15 June, 2020

asx

Resignation & Appointment of Company Secretary

24 June, 2020

asx

Sale of Ellex Lasers & Ultrasound Now Unconditional

26 June, 2020

asx

Change in Substantial Holding from AEF

30 June, 2020

asx

Completion of Lumibird Transaction

30 June, 2020

asx

Change of Company Name

1 July, 2020

asx

Molteno Acquistion

2 July, 2020

Subscribe to investor updates

This website uses cookies to ensure you get the best experience on our website.
The cookies do not store any personalised information. Learn More

Treatments

Products

Conditions

About Ellex

Investors

No results found

Quick Links

Select your location